Riboflavin-ultraviolet A (UVA) collagen cross-linking has not only achieved good clinical efficacy in the treatment of corneal diseases such as dilatation keratopathy, bullae keratopathy, infectious keratopathy, and in the combined treatment of corneal refractive surgeries, but also its efficacy and safety in scleral collagen cross-linking have been initially confirmed. To better promote the application of cross-linking in the clinical treatment of corneal and scleral diseases, exploring controllability and predictability of the surgical efficacy are both important for evaluating the surgical efficacy and personalized precision treatment. In this paper, the progress on the cross-linking depth of riboflavin-UVA collagen cross-linking, and its relationship with the cross-linking effect will be reviewed. It will provide the reference for further application of this procedure in ophthalmology clinics.
Citation：
LIU Xiaona, LI Xiaona, CHEN Weiyi. Controllability and predictability of riboflavin-ultraviolet A collagen cross-linking: advances in experimental techniques and theoretical research. Journal of Biomedical Engineering, 2025, 42(1): 212-218. doi: 10.7507/1001-5515.202402017
Copy
Copyright © the editorial department of Journal of Biomedical Engineering of West China Medical Publisher. All rights reserved
| 1. |
|
| 2. |
|
| 3. |
|
| 4. |
|
| 5. |
|
| 6. |
|
| 7. |
|
| 8. |
|
| 9. |
|
| 10. |
|
| 11. |
|
| 12. |
|
| 13. |
|
| 14. |
|
| 15. |
|
| 16. |
Fan L, Jung O, Herrmann M, et al. Deciphering UVA/riboflavin collagen crosslinking: a pathway to improve biomedical materials. Adv Funct Mater, 2024: 2401742.
|
| 17. |
|
| 18. |
|
| 19. |
|
| 20. |
|
| 21. |
|
| 22. |
|
| 23. |
|
| 24. |
McQuaid R M. Diffusion of oxygen and riboflavin during corneal cross-Linking (CXL). University College Dublin (Ireland), 2017.
|
| 25. |
|
| 26. |
|
| 27. |
|
| 28. |
|
| 29. |
|
| 30. |
|
| 31. |
|
| 32. |
|
| 33. |
|
| 34. |
|
| 35. |
|
| 36. |
|
| 37. |
|
| 38. |
|
| 39. |
|
| 40. |
|
| 41. |
|
| 42. |
|
| 43. |
Vinas-Pena M, Feng X, Li G Y, et al. In situ measurement of the stiffness increase in the posterior sclera after UV-riboflavin crosslinking by optical coherence elastography. Biomed Opt Express, 2022, 13(10): 5434-5446.
|
| 44. |
|
| 45. |
|
| 46. |
|
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16. Fan L, Jung O, Herrmann M, et al. Deciphering UVA/riboflavin collagen crosslinking: a pathway to improve biomedical materials. Adv Funct Mater, 2024: 2401742.
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24. McQuaid R M. Diffusion of oxygen and riboflavin during corneal cross-Linking (CXL). University College Dublin (Ireland), 2017.
- 25.
- 26.
- 27.
- 28.
- 29.
- 30.
- 31.
- 32.
- 33.
- 34.
- 35.
- 36.
- 37.
- 38.
- 39.
- 40.
- 41.
- 42.
- 43. Vinas-Pena M, Feng X, Li G Y, et al. In situ measurement of the stiffness increase in the posterior sclera after UV-riboflavin crosslinking by optical coherence elastography. Biomed Opt Express, 2022, 13(10): 5434-5446.
- 44.
- 45.
- 46.
